For example, OICR-9429 selectively inhibits proliferation and induces differentiation of human acute myeloid leukemia (AML) cells expressing C/EBPα p30, a mutation present in 9% of AML patients [32]. This evidence concerns the gene CEBPA and acute myeloid leukemia.